PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33513156-9	2021	We also examined the therapeutic efficacy of these drugs in combination with cytosine arabinoside and the effects of SLFN11 on the efficacy of cytosine arabinoside in SLFN11-overexpressing cells.	Cytarabine	143-163	schlafen family member 11	Homo sapiens	117-123	
33513156-9	2021	We also examined the therapeutic efficacy of these drugs in combination with cytosine arabinoside and the effects of SLFN11 on the efficacy of cytosine arabinoside in SLFN11-overexpressing cells.	Cytarabine	143-163	schlafen family member 11	Homo sapiens	167-173	
33513156-12	2021	The EZH2 and HDAC epigenetic modifiers upregulated SLFN11 expression in GCB-derived lymphoma cells and made them more susceptible to cytosine arabinoside.	Cytarabine	133-153	schlafen family member 11	Homo sapiens	51-57	
33513156-13	2021	SLFN11 overexpression further sensitized GCB-derived lymphoma cells to cytosine arabinoside.	Cytarabine	71-91	schlafen family member 11	Homo sapiens	0-6	
33513156-15	2021	GCB-derived lymphomas with low SLFN11 expression can be treated by the combination of epigenetic modifiers and cytosine arabinoside.	Cytarabine	111-131	schlafen family member 11	Homo sapiens	31-37